You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

PHENOXYBENZAMINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for phenoxybenzamine hydrochloride and what is the scope of patent protection?

Phenoxybenzamine hydrochloride is the generic ingredient in two branded drugs marketed by Concordia, Amneal, Aurobindo Pharma, Hikma, Novitium Pharma, Par Pharm Inc, and Rising, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.

There are six drug master file entries for phenoxybenzamine hydrochloride. Six suppliers are listed for this compound.

Summary for PHENOXYBENZAMINE HYDROCHLORIDE
Recent Clinical Trials for PHENOXYBENZAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Seoul National University HospitalPhase 4
University of California, Los AngelesPhase 3
Atrium Medical CenterPhase 4

See all PHENOXYBENZAMINE HYDROCHLORIDE clinical trials

Pharmacology for PHENOXYBENZAMINE HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PHENOXYBENZAMINE HYDROCHLORIDE

US Patents and Regulatory Information for PHENOXYBENZAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Concordia DIBENZYLINE phenoxybenzamine hydrochloride CAPSULE;ORAL 008708-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Par Pharm Inc PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 204522-001 Jan 24, 2017 AB RX No Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Hikma PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 201050-001 Jul 16, 2012 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Amneal PHENOXYBENZAMINE HYDROCHLORIDE phenoxybenzamine hydrochloride CAPSULE;ORAL 212568-001 Oct 27, 2020 AB RX No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.